Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Nucleonex Inc., headquartered in California, is a pioneering force in the biotechnology industry, specialising in advanced nuclear medicine solutions. Founded in 2015, the company has rapidly established itself as a leader in the development of innovative radiopharmaceuticals, focusing on targeted therapies for cancer treatment.
With a commitment to enhancing patient outcomes, Nucleonex offers unique products that leverage cutting-edge technology to deliver precise and effective treatments. The company has achieved significant milestones, including successful clinical trials and partnerships with leading healthcare institutions, solidifying its position in the market.
Nucleonex Inc. continues to push the boundaries of nuclear medicine, striving to improve therapeutic options and contribute to the evolving landscape of oncology care.
+11 vs industry average
Nucleonex Inc.’s score of 54 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nuclear Fuel is among the most carbon-intensive industries
The Nuclear Fuel industry has reduced its overall emissions by 9% since 2018
No reported emissions data is available for Nucleonex Inc. yet.
Nucleonex Inc., headquartered in California, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of AtkinsRéalis Group Inc., which may influence its climate commitments and reporting practices.
While Nucleonex Inc. has not established its own reduction targets or climate pledges, it inherits initiatives and performance metrics from its parent company, AtkinsRéalis Group Inc. This includes participation in various sustainability frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from AtkinsRéalis Group Inc. at a level 2 relationship.
As part of its corporate family, Nucleonex Inc. aligns with the broader climate strategies and commitments of AtkinsRéalis Group Inc., which may include industry-standard practices aimed at reducing carbon footprints and enhancing sustainability. However, specific details regarding these initiatives or targets are not available for Nucleonex Inc. at this time.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Nucleonex Inc. yet.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more